 Mutated Genes and Abnormal Protein Expression
|
| Gene | Location | Topics
|
| SLC2A1 (
GLUT1
)
| 1p35-p31.3
|
-GLUT1 Overexpression in Gastric Cancer
|
| RUNX3 (
AML2
, CBFA3
, PEBP2A3
)
| 1p36
|
-RUNX3 in Gastric Cancer
|
| MUC1 (
PUM
, PEM
)
| 1q21
|
-MUC1 and Gastric Cancer
|
| PTGS2 (
COX2
)
| 1q25.2-q25.3
|
-PTSG2 (cox2) Overexpression in Gastric Cancer
|
| MSH6 (
HNPCC5
, GTBP
)
| 2p16
|
-MSH6 and Gastric Cancer
|
| FHIT | 3p14.2
|
-FHIT and Gastric Cancers
|
| MLH1 (
HNPCC2
, COCA2
, FCC2
)
| 3p21.3
|
-MLH1 and Familial Gastric Cancer
|
| TGFBR2 | 3p22
|
-TGFBR2 and Gastric Cancer
|
| CTNNB1 (
CTNNB
)
| 3p22-p21.3
|
-CTNNB1 and Gastric Cancer
|
| APC (
FPC
, DP2
, DP3
)
| 5q21-q22
|
-APC and Gastric Cancer
-APC and FAP Associated Gastric Cancer
|
| CDKN1A (
P21
, WAF1
, CIP1
)
| 6p21.2
|
-CDKN1A Expression in Esophageal Cancer
|
| CD44 (
MDU3
, HA
, MDU2
)
| 11pter-p13
|
-CD44 and Gastric Cancer
|
| CDKN1B (
KIP1
, P27
)
| 12p13
|
-CDKN1B and Gastric Cancer
|
| ING1 | 13q34
|
-ING1 Supression in Gastric Cancer
|
| CDH1 (
UVO
)
| 16q22.1
|
-CDH1 Mutations in Familial Gastric Cancer
|
| TP53 (
p53
, P53
)
| 17p13.1
|
-TP53 and Gastric Cancer
|
| DCC (
CRC18
, CRCR1
)
| 18q21.3
|
-DCC and Gastric Cancer
|
| BAX | 19q13.3-q13.4
|
-BAX and Gastric Carcinoma
|
| PYGB | 20p11.2-p11.1
|
-PYGB Expression in Gastric Cancer
|
| TNFRSF6B (
DCR3
, M68
)
| 20q13.3
|
-TNFRSF6B Overexpression in Gastric Cancer
|
|
Stomach (Gastric) Cancer: Clinical and Epidemiological Resources